staurosporine has been researched along with sb 415286 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bowler, AN; Ehrbar, U; Hansen, BF; Kurtzhals, P; Olesen, PH; Sørensen, AR; Ursø, B | 1 |
| Flajolet, M; Greengard, P; Meijer, L | 1 |
| Jagarlapudi, SA; Sinha, BN; Tajne, S; Vadivelan, S | 1 |
| Arnost, M; Green, J; Lauffer, D; Madden, J; Pierce, A; Tanner, K; ter Haar, E | 1 |
| Chen, H; Ding, H; Gao, Y; Jiang, X; Liu, W; Liu, X; Tian, L; Xu, Z; Zhao, Q | 1 |
| Alavian, K; Hakkinen, L; Koivisto, L; Larjava, H; McCulloch, CA; Pelech, S | 1 |
| Häkkinen, L; Koivisto, L; Larjava, H; Matsumoto, K; McCulloch, CA; Yamada, KM | 1 |
1 review(s) available for staurosporine and sb 415286
| Article | Year |
|---|---|
Pharmacological inhibitors of glycogen synthase kinase 3.
Topics: Animals; Cell Differentiation; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Humans; Neoplasms; Nervous System Diseases; Parasitic Diseases; Signal Transduction; Stem Cells; Structure-Activity Relationship | 2004 |
6 other study(ies) available for staurosporine and sb 415286
| Article | Year |
|---|---|
Synthesis and in vitro characterization of 1-(4-aminofurazan-3-yl)-5-dialkylaminomethyl-1H-[1,2,3]triazole-4-carboxylic acid derivatives. A new class of selective GSK-3 inhibitors.
Topics: Animals; beta Catenin; CHO Cells; Cricetinae; Cytoskeletal Proteins; Databases, Factual; Enzyme Inhibitors; Glycogen; Glycogen Synthase Kinase 3; Humans; In Vitro Techniques; Male; Muscle, Skeletal; Oxadiazoles; Rats; Rats, Wistar; Solubility; Structure-Activity Relationship; Trans-Activators; Triazoles; Water | 2003 |
Fragment and knowledge-based design of selective GSK-3beta inhibitors using virtual screening models.
Topics: Algorithms; Computer Simulation; Databases, Factual; Drug Design; Drug Evaluation, Preclinical; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Models, Chemical; Models, Molecular; Molecular Structure; Oxazines; Protein Kinase Inhibitors; Quinazolines; Reproducibility of Results; Stereoisomerism; Structure-Activity Relationship | 2009 |
3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3beta.
Topics: Binding Sites; Crystallography, X-Ray; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Ligands; Protein Binding; Protein Kinase Inhibitors; Protein Kinases; Pyrazolones; Structure-Activity Relationship | 2010 |
Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Dyrk Kinases; Glycogen Synthase Kinase 3 beta; Harmine; Humans; Models, Molecular; Molecular Structure; Neuroprotective Agents; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Structure-Activity Relationship | 2021 |
Glycogen synthase kinase-3 regulates formation of long lamellipodia in human keratinocytes.
Topics: Aminophenols; Benzoquinones; Calcium; Cells, Cultured; Egtazic Acid; Enzyme Inhibitors; Fibronectins; Genistein; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Keratinocytes; Lactams, Macrocyclic; Maleimides; Phospholipase C gamma; Phosphorylation; Protein Serine-Threonine Kinases; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Pseudopodia; Quinones; Rifabutin; Staurosporine; Type C Phospholipases; Vanadates; Wound Healing | 2003 |
Glycogen synthase kinase-3 regulates cytoskeleton and translocation of Rac1 in long cellular extensions of human keratinocytes.
Topics: Aminophenols; Cells, Cultured; Colchicine; Cytochalasin D; Cytoskeleton; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Glycogen Synthase Kinase 3; Humans; Keratinocytes; Lithium Chloride; Maleimides; Nocodazole; Nucleic Acid Synthesis Inhibitors; Paclitaxel; Pseudopodia; rac1 GTP-Binding Protein; Staurosporine | 2004 |